Variable | Disease category | ||||
---|---|---|---|---|---|
All | RA | SnA | PsA | ReA | |
*Refers to patients who underwent synovial tissue biopsy after treatment. | |||||
DMARD, disease modifying antirheumatic drug; MTX, methotrexate; PsA, psoriatic arthritis; RA, rheumatoid arthritis; ReA, reactive arthritis; SnA, seronegative arthritis; SSZ, sulphasalazine. | |||||
Number of patients | 28 | 12 | 9 | 5 | 2 |
Mean age (years) (median; range) | 34 (35; 19 to 59) | 37 (37; 19 to 59) | 30 (32; 19 to 43) | 34 (39; 21 to 41) | 37 (−) |
Sex (male/female) (n) | 13/15 | 4/8 | 7/2 | 2/3 | 0/2 |
Mean symptom duration (months) (median; range) | 8 (6; 1 to 36) | 9 (6; 1 to 23) | 4 (3; 1 to 11) | 17 (14; 6 to 36) | 1 (–) |
DMARD started (n): MTX/SSZ* | 7/5 | 4/0 | 1/4 | 2/1 | to |
Mean C reactive protein (mg/l) (median; range) | 41 (22; 0 to 162) | 36 (21; 0 to 162) | 51 (54; 0 to 108) | 33 (0; 0 to 87) | 47 (47; 0 to 95) |